Traditional Therapy Profiles · Formulation

Mahayogaraja Guggulu

Also called: Maha Yogaraja Guggulu, Maha Yogaraj Guggulu

Many ingredients: guggulu · herbs · minerals

"Maha" is not emphasis. It is a different recipe.

New here? How to read these profiles

The important distinction

Mahayogaraja sits in the yogaraja recipe family. Patients often hear Yogaraja and Mahayogaraja as one product with a longer or shorter name. They are distinct classical formulations, not nicknames for the same tablet.

What it is

A classical Ayurvedic guggulu vati in the yogaraja recipe family, built around guggulu resin with a broad herb set and, in many formularies, additional processed minerals and rasas.

It is one named member of that family, not a longer nickname for Yogaraja Guggulu.

Where you will encounter it

  • Prescriptions and pharmacy labels that say Mahayogaraja, Maha Yogaraja, or Maha Yograj
  • Family speech that shortens the name to "yogaraja guggul" or "guggulu for joints"
  • OTC joint shelves where yogaraja-family tablets sit beside Commiphora extract capsules
  • Multimodal OA regimens pairing oral vati with medicated oils or adjunct churna

Further detail

Recipe family

"Maha" is not emphasis. It is a different recipe.

Yogaraja and Mahayogaraja are distinct classical formulations within one recipe family. Exact ingredient lists vary by text and manufacturer. In many formularies, the Mahayogaraja lane characteristically includes additional processed minerals and rasas that Yogaraja recipes do not. That is a compositional identity, not a stronger dose of the same tablet.

Names encode recipe identity.

What human research has studied

Evidence attaches to named family members and protocols, not the family stem.

Comparative trials and open-label OA work often name Yograj or Yogaraja Guggulu inside multimodal regimens with ashwagandha, oral tablets, and topical oil. Preclinical work exists on Mahayogaraja batches specifically.

A result on one family member does not license the other. The evidence file follows the classical name on the protocol, not the shared yogaraja syllables.

What the evidence does not justify
  • Treating Mahayogaraja as a longer name for Yogaraja
  • Applying a Yogaraja trial result to a Mahayogaraja bottle without reading the classical name
  • Treating multimodal OA protocol results as proof of oral tablets alone
  • Ignoring recipe-level mineral and rasa content when reviewing safety
Questions worth asking

The useful first question is rarely "Is guggulu good for joints?" It is "Does the label say Mahayogaraja or Yogaraja in full?"

  • Does the label say Mahayogaraja, Maha Yogaraja, Yogaraja, or Yograj?
  • Oral tablets only, or combined with oils or exercise programs?
  • NSAIDs, methotrexate, or thyroid medicines already in use?
  • Was a family member substituted at the pharmacy without the prescriber knowing?
Safety and interaction attention

Safety follows the recipe identity, not the family stem.

In many Mahayogaraja formularies, processed minerals and rasas change the review questions beyond plant-only joint care. Guggulsterone thyroid interaction reports remain relevant. NSAID co-use and herbomineral polypharmacy deserve explicit mention. Exact loads vary by manufacturer and lineage, which is why the full classical name and label matter.

Related entries

Recipe family members under the guggulu stem. Each name encodes a different medicine.

  1. Yogaraja Guggulu Formulation Near-name family member. Different classical recipe, not a shorter name for this tablet.
  2. Guggulu Ingredient The naming stem. Teaches resin vs named vati, not recipe-family architecture.
  3. Simhanada Guggulu Formulation Another joint-shelf neighbor with an inflammatory amavata lane, not the yogaraja family.

Commonly confused with

  • Yogaraja Guggulu treated as a shorter name for the same tablet
  • Commiphora or guggul extract capsules marketed for joints
  • Simhanada Guggulu filed under the same joint habit without reading the classical lane
Sources
  1. Makhija D, et al. Evaluation of Yograj Guggulu, Ashwagandha Churna and Narayana Taila in management of osteoarthritis knee. J Ayurveda Integr Med. 2024. doi:10.1016/j.jaim.2024.101077
  2. Anonymous. A comparative clinical study to evaluate the efficacy of Abha Guggulu and Yogaraja Guggulu in Janu Sandhigata Vata. Int Ayurvedic Med J. 2021. doi:10.46607/iamj0409092021
  3. Patwardhan B, et al. Antiinflammatory activity of two Ayurvedic formulations containing guggul. Indian J Pharm Sci. 2004. doi:10.4103/0253-7613.19080 (Mahayogaraja Guggulu preclinical context)

Evidence blocks last reviewed: July 2026.

← Back to Traditional Therapy Profiles